Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
13%
Ph not_applicable
1
13%
Ph phase_3
1
13%
Ph phase_4
4
50%

Phase Distribution

1

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
4(57.1%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(5)
Other(3)

Detailed Status

Completed5
unknown3

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 31 (14.3%)
Phase 44 (57.1%)
N/A1 (14.3%)

Trials by Status

unknown338%
completed563%

Recent Activity

0 active trials
Showing 5 of 8
completed

Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate

NCT05083299
completedphase_4

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

NCT06046196
unknownphase_4

The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm

NCT01674686
completedphase_4

Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease

NCT02607436
completedphase_1

Sarpogrelate Drug Interaction

NCT02097511
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05083299

Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate

Completed
NCT06046196Phase 4

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

Completed
NCT01674686Phase 4

The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm

Unknown
NCT02607436Phase 4

Effect of Sarpogrelate, a Serotonin Receptor Antagonist, on Coronary Artery Disease

Completed
NCT02097511Phase 1

Sarpogrelate Drug Interaction

Completed
NCT02294643Phase 3

Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study

Completed
NCT01548274Not Applicable

Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells

Unknown
NCT01165567Phase 4

The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease

Unknown

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8